Avermectin derivatives
US7250402B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2004 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Nov 29, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound represented by the general formula (I) or a salt thereof:whereinrepresents —CH═CH—, —CH2—CH2— or the like,between R1 and the carbon atom at 4′-position represents a single bond or a double bond,between R2 and the carbon atom at 5-position represents a single bond or a double bond, and for example, 1) whenrepresents —CH═CH— or —CH2—CH2—, andbetween R1 and the carbon atom at 4′-position represents a double bond, R1 represents ═C(R11)(R12) (wherein R11 represents a lower alkyl group or the like and R12 represents a hydrogen atom or the like) or the like, and R2 represents a hydroxyl group or the like, or R2 may be combined together with the carbon atom at 5-position to form a carbonyl group, and 2) whenrepresents —CH═CH— or —CH2—CH2—, andbetween R1 and the carbon atom at 4′-position represents a single bond, R1 represents —OCH(R1a)(R1b) (wherein R1a represents a lower alkyl or the like and R1b represents a hydrogen atom or the like) or the like, and R2 represents a hydroxyl group or the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.